Topics

Resistance to last resort drug arose in patient over 3 weeks

09:50 EDT 21 Oct 2019 | Science Daily

French investigators have described development of resistance to one of the last resort therapies used to treat extremely drug-resistant Pseudomonas aeruginosa. That resistance arose in a single patient over a scant 22 days. They subsequently identified the single nucleotide mutation in P. aeruginosa that caused the resistance.

Original Article: Resistance to last resort drug arose in patient over 3 weeks

NEXT ARTICLE

More From BioPortfolio on "Resistance to last resort drug arose in patient over 3 weeks"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...